Nagy N - Search Results

1

Human ex vivo carcinoma cells produce transforming growth factor beta and thereby can inhibit lymphocyte functions in vitro.

Vánky F, Nagy N, Hising C, Sjövall K, Larson B, Klein E. Vánky F, et al. Among authors: nagy n. Cancer Immunol Immunother. 1997 Jan;43(6):317-23. doi: 10.1007/s002620050339. Cancer Immunol Immunother. 1997. PMID: 9067402 Free PMC article.

2

Transforming growth factor beta, (TGFbeta) secreted by immunogenic ex vivo human carcinoma cells, counteracts the activation and inhibits the function of autologous cytotoxic lymphocytes. Pretreatment with interferon gamma and tumor necrosis factor alpha reduces the production of active TGFbeta.

Nagy N, Vánky F. Nagy N, et al. Cancer Immunol Immunother. 1998 Feb;45(6):306-12. doi: 10.1007/s002620050447. Cancer Immunol Immunother. 1998. PMID: 9490200 Free PMC article.

3

Tumor surveillance: expression of the transporter associated with antigen processing (TAP-1) in ex-vivo human tumor samples and its elevation by in vitro treatment with IFN-gamma and TNF-alpha.

Nagy N, Vánky F, Klein E. Nagy N, et al. Immunol Lett. 1998 Dec;64(2-3):153-60. doi: 10.1016/s0165-2478(98)00104-7. Immunol Lett. 1998. PMID: 9870667

4

SH2D1A expression reflects activation of T and NK cells in cord blood lymphocytes infected with EBV and treated with the immunomodulator PSK.

Liu A, Klein G, Bandobashi K, Klein E, Nagy N. Liu A, et al. Among authors: nagy n. Immunol Lett. 2002 Mar 1;80(3):181-8. doi: 10.1016/s0165-2478(01)00330-3. Immunol Lett. 2002. PMID: 11803050

5

Deficiency of the proapoptotic SAP function in X-linked lymphoproliferative disease aggravates Epstein-Barr virus (EBV) induced mononucleosis and promotes lymphoma development.

Nagy N, Klein E. Nagy N, et al. Immunol Lett. 2010 May 4;130(1-2):13-8. doi: 10.1016/j.imlet.2010.01.002. Epub 2010 Jan 18. Immunol Lett. 2010. PMID: 20080127 Review.

6

Modification of cell differentiation, one of the mechanisms in the surveillance of malignancy.

Klein E, Nagy N, Rasul E. Klein E, et al. Among authors: nagy n. Cancer Immunol Res. 2015 Feb;3(2):97-102. doi: 10.1158/2326-6066.CIR-14-0238. Cancer Immunol Res. 2015. PMID: 25660552 Review.

7

A repetitive sequence of Epstein-Barr virus nuclear antigen 6 comprises overlapping T cell epitopes which induce HLA-DR-restricted CD4(+) T lymphocytes.

Rajnavölgyi E, Nagy N, Thuresson B, Dosztányi Z, Simon A, Simon I, Karr RW, Ernberg I, Klein E, Falk KI. Rajnavölgyi E, et al. Among authors: nagy n. Int Immunol. 2000 Mar;12(3):281-93. doi: 10.1093/intimm/12.3.281. Int Immunol. 2000. PMID: 10700463

8

The X-linked lymphoproliferative disease gene product SAP is expressed in activated T and NK cells.

Nagy N, Mattsson K, Maeda A, Liu A, Székely L, Klein E. Nagy N, et al. Immunol Lett. 2002 Jun 3;82(1-2):141-7. doi: 10.1016/s0165-2478(02)00029-9. Immunol Lett. 2002. PMID: 12008045

9

Expression of SH2D1A in five classical Hodgkin's disease-derived cell lines.

Kis LL, Nagy N, Klein G, Klein E. Kis LL, et al. Among authors: nagy n. Int J Cancer. 2003 May 1;104(5):658-61. doi: 10.1002/ijc.10986. Int J Cancer. 2003. PMID: 12594824

10

Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1.

Kis LL, Takahara M, Nagy N, Klein G, Klein E. Kis LL, et al. Among authors: nagy n. Immunol Lett. 2006 Apr 15;104(1-2):83-8. doi: 10.1016/j.imlet.2005.11.003. Epub 2005 Dec 1. Immunol Lett. 2006. PMID: 16386314 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

664 results

Search Page

Filters